Avalo Therapeutics, Inc. · NASDAQ:AVTX
Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.80% (Schedule 13G)
Event Feb 10, 2026 · Filed Feb 17, 2026
Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.80%, 887,274 shares, as a passive investor on Feb 10, 2026. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 4.80%
- Shares
- 887,274
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Millennium Management LLC | 4.80% | 887,274 |
| Millennium Group Management LLC | 4.80% | 887,274 |
| Israel A. Englander | 4.80% | 887,274 |
Source
Related
- Avalo Therapeutics, Inc.
- Millennium Management LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jul 6, 2026
- Schedule 13G · Millennium Management LLC · Feb 24, 2026
- Schedule 13G · Millennium Management LLC · Feb 10, 2026
- Schedule 13G · Millennium Management LLC · Feb 3, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026